| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0044 | 1 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.00069 | 1 |